PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 9, 2026ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR0 citationsOpen Access

Correlation Between Venous Excess Ultrasound and N-Terminal Pro-B-Type Natriuretic Peptide Levels in Patients With Acute Decompensated Heart Failure

MFMarcella Pereira FloresASAlexandre Costa SouzaMCMarcus Vinicius Silva Freire de Carvalho

Key Points

  • This study aims to evaluate the relationship between the VExUS score and serum NT-proBNP levels in patients with acute decompensated heart failure.
  • Retrospective observational study of 117 patients hospitalized with ADHF.

Structured PICO

Does the VExUS score correlate with NT-proBNP levels in patients hospitalized with acute decompensated heart failure?

P
Population
117 hospitalized patients with acute decompensated heart failure (ADHF), median age 79, 54.7% male, based in Brazil. Key exclusions: advanced liver disease, incomplete ultrasound records, or no NT-proBNP measurement within 24 hours.
I
Intervention
Venous Excess Ultrasound (VExUS) score assessment within the first 24 hours of hospital admission
O
Outcome
Correlation between VExUS score and serum NT-proBNP levels (pg/mL) within the first 24 hours of admissionsurrogate

The VExUS score moderately correlates with NT-proBNP levels in acute decompensated heart failure, supporting its use as a complementary bedside tool for assessing systemic venous congestion.

Limitations

  • Cross-sectional design limits the ability to infer causal relationships or evaluate dynamic changes during hospitalization
  • Single-center study
  • Short 24-hour time window may be affected by therapeutic interventions initiated during this period
  • VExUS interpretation can be influenced by tricuspid regurgitation, atrial fibrillation, and parenchymal liver diseases

Abstract

Background: The Venous Excess Ultrasound (VExUS) score has been proposed as an ultrasonographic method for assessing systemic venous congestion in patients with acute decompensated heart failure (ADHF).However, the relationship between VExUS and the biomarker N-terminal pro-B-type natriuretic peptide (NT-proBNP) remains unclear in literature.Objectives: To evaluate the correlation between the VExUS score and serum NT-proBNP levels in patients with ADHF.Methods: This retrospective observational study included 117 patients hospitalized with ADHF.Systemic venous congestion was assessed using the VExUS score, and serum NT-proBNP levels were obtained from laboratory records.Comparisons between groups were performed using the Kruskal-Wallis test, followed by Dunn's test for multiple comparisons.The strength of association between variables was analyzed using Spearman's correlation coefficient.Results: NT-proBNP levels increased progressively with increasing VExUS severity, with median values of 2,890 pg/mL (VExUS 0), 4,700 pg/mL (VExUS 1), 5,430 pg/mL (VExUS 2), and 13,200 pg/mL (VExUS 3).Statistical analysis demonstrated a significant difference between groups (Kruskal-Wallis: 2 = 39.18;p < 0.0001).Dunn's test indicated that patients with VExUS 3 had significantly higher NT-proBNP levels compared with the other groups (p < 0.01).A moderate positive correlation was observed between the variables (Spearman's coefficient = 0.567; p < 0.0001). Conclusion:The results indicate that the VExUS score is associated with NT-proBNP levels and may be integrated into clinical reasoning when assessing venous congestion in patients with ADHF.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Flores et al. (2026) studied this question.

synapsesocial.com/papers/69fece83b9154b0b82875f66https://doi.org/10.36660/abcimg.20260018i
Ask AI
Helpful
Bookmark
Share
View Full Paper